Nature Reviews Gastroenterology & Hepatology is a peer-reviewed medical journal. Before April 2009, it was titled Nature Clinical Practice Gastroenterology & Hepatology. It was established in 2004 and is published by the Nature Publishing Group.
Isis is a quarterly peer-reviewed academic journal published by the University of Chicago Press. It covers the history of science, history of medicine, and the history of technology, as well as their cultural influences. It contains original research articles and extensive book reviews and review essays. Furthermore, sections devoted to one particular topic are published in each issue in open access. These sections consist of the Focus section, the Viewpoint section and the Second Look section.
The Journal of Asian Studies is a quarterly peer-reviewed academic journal published by Cambridge University Press on behalf of the Association for Asian Studies, covering Asian studies, ranging from history, the arts, social sciences, to philosophy of East, South, and Southeast Asia. In addition to regular articles, a large section of the journal is devoted to book reviews. The journal was established in 1941 as The Far Eastern Quarterly, changing to its current title in September 1956.
Marine Drugs is a peer-reviewed open-access medical journal publishing reviews and regular research papers on the research, development, and production of therapeutic agents from marine natural products. It is published by MDPI and was established in 2003. The editor-in-chief is Prof. Orazio Taglialatela-Scafati.
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field.
Energy & Environmental Science is a monthly peer-reviewed scientific journal publishing original (primary) research and review articles. The journal covers work of an interdisciplinary nature in the biochemical and biophysical sciences and chemical engineering disciplines. Energy & Environmental Science is published by the Royal Society of Chemistry and the editor-in-chief is Joseph Hupp,.
Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis.
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse. The journal was established in 2001 and according to the Journal Citation Reports, it has a 2016 impact factor of 3.684. The journal is also indexed in MEDLINE.
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas.
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group. The editor-in-chief is Uday Kompella.
Expert Opinion on Drug Safety is a monthly peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre.
Expert Opinion on Emerging Drugs is a quarterly peer-reviewed medical journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas. Each review includes an "expert opinion" section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed. It is published by Informa. According to the Journal Citation Reports, the journal has a 2014 impact factor of 3.058.
Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio.
Biochemical Pharmacology is a peer-reviewed medical journal published by Elsevier. It covers research on the pharmacodynamics and pharmacokinetics of drugs and non-therapeutic xenobiotics. The editor-in-chief is S. J. Enna, University of Kansas Medical Center, Kansas City.
Current Opinion in Neurology is a bimonthly peer-reviewed medical journal covering neurology. The journal publishes editorials and reviews, but not original research articles. It is published by Lippincott Williams & Wilkins and the editor-in-chief is Richard S.J. Frackowiak. The journal was established in 1988 as Current Opinion in Neurology and Neurosurgery and obtained its current name in 1993.
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley.
Expert Review of Gastroenterology & Hepatology is a peer-reviewed medical journal covering all aspects of gastroenterology and hepatology. It was established in 2007 and is published by Informa.
Expert Review of Anti-infective Therapy is a monthly peer-reviewed medical journal publishing review articles and original papers on all aspects of anti-infective therapy. The journal was established in 2003 and is published by Informa.
Lemborexant (INN) (code name E-2006) is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia. In June 2016, Eisai initiated phase 3 clinical trials which are currently underway in the US, France, Germany, Italy, Japan, Poland, Spain and the UK, and are expected to extend to Canada.
